{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Pfizer", "item": "https://www.patentleaderboard.com/2021/company/pfizer"}, {"@type": "ListItem", "position": 4, "name": "Bruce N. Rogers", "item": "https://www.patentleaderboard.com/2021/inventor/fl:br_ln:rogers-18"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
BR

Bruce N. Rogers — 7 Patents in 2021

MTMorphic Therapeutic: 6 patents #1 of 24Top 5%
Pfizer: 1 patents #97 of 325Top 30%
Belmont, MA: #5 of 237 inventorsTop 3%
Massachusetts: #303 of 14,123 inventorsTop 3%
Overall (2021): #18,074 of 548,734Top 4%
7 Patents 2021

Issued Patents 2021

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11174228 Antagonists of human integrin (α4)(β7) Matthew G. Bursavich, Dawn M. Troast, Bryce A. Harrison, Blaise S. Lippa, Kyle D. Konze +9 more 2021-11-16
11104661 Inhibiting human integrin (α-4) (β-7) Matthew G. Bursavich, Dan Cui, James E. Dowling, Kristopher N. Hahn, Bryce A. Harrison +12 more 2021-08-31
11046669 Inhibitors of (α-v)(β-6) integrin Bryce A. Harrison, Matthew G. Bursavich, Mark Brewer, Aleksey I. Gerasyuto, Kristopher N. Hahn +6 more 2021-06-29
11046685 Inhibitors of (α-v)(β-6) integrin Bryce A. Harrison, Matthew G. Bursavich, Aleksey I. Gerasyuto, Kristopher N. Hahn, Kyle D. Konze +5 more 2021-06-29
11040955 Inhibitors of (alpha-v)(beta-6) integrin Mark Brewer, Matthew G. Bursavich, Aleksey I. Gerasyuto, Kristopher N. Hahn, Bryce A. Harrison +6 more 2021-06-22
11021480 Inhibiting (α-V)(β-6) integrin Bryce A. Harrison, James E. Dowling, Matthew G. Bursavich, Dawn M. Troast, Blaise S. Lippa +6 more 2021-06-01
11014909 Heteroaromatic compounds and their use as dopamine D1 ligands Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more 2021-05-25 $425,301,000